Methylene BlueThird Party Manufacturing in India

Methylene Blue works by accelerating the conversion of methemoglobin back to functional hemoglobin in the blood.

In low doses, it acts as a reducing agent, accelerating the enzymatic reduction of methemoglobin by NADPH-methemoglobin reductase. This biological effect helps the body restore the oxygen-carrying capacity of red blood cells, preventing tissue hypoxia and cellular damage.

Unlike other treatments for methemoglobinemia, Methylene Blue provides rapid, life-saving reversal of symptoms. It is highly effective for patients experiencing acquired methemoglobinemia induced by drugs or toxic chemicals.

Therapeutic Uses

Methylene Blue is prescribed for the treatment of:

• Methemoglobinemia: Acts as an essential antidote for drug-induced or toxin-induced methemoglobinemia, restoring normal blood oxygenation.
• Vasoplegic Syndrome: Used in critical care and cardiac surgery to treat refractory hypotension.
• Diagnostic Agent: Utilized as a surgical dye and indicator in various medical and surgical diagnostic procedures.

Why Manufacturers Choose Methylene Blue

Methylene Blue is a critical, life-saving antidote with consistent demand in hospitals and emergency care settings. Its unique pharmacological properties make it an essential item on emergency room formularies worldwide.

This makes Methylene Blue a sought-after molecule for third party manufacturing in India, with consistent demand from hospital supply chains and export-oriented companies fulfilling institutional tenders.